Home » Topics » Regulatory » EMA

EMA
RSS

Halaven receives positive CHMP opinion on new indication in Europe

April 6, 2016

EMA committee recommends approval of pandemic influenza vaccine

April 4, 2016

Xilonix will undergo accelerated assessment in E.U.

April 4, 2016

CHMP recommends approval of Strimvelis for ADA-SCID

April 4, 2016

Samsung Bioepis' infliximab biosimilar receives positive opinion in E.U.

April 4, 2016

EMA's CHMP backs approval of Trevicta for schizophrenia

April 4, 2016

Amicus' migalastat gets positive opinion from EMA for Fabry disease

April 4, 2016

EMA's COMP backs orphan drug designation for CDNF in ALS

March 31, 2016

Coagadex receives approval in Europe

March 31, 2016

Ubenimex awarded orphan drug designation in E.U. for PAH

March 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...